Tentative Schedule

25th American Peptide Symposium – June 17-22, 2017 – Whistler BC

Saturday, June 17, 2017

01:00 pm - 06:00 pm Registration Grand Foyer
02:00 pm - 05:30 pm APS Council Meeting To Be Announced
04:00 pm - 05:30 pm L01, KN Workshop:
How to Break Bottlenecks in Your Peptide Synthesis Workflow.
Elizabeth Denton, PhD
06:00 pm - 07:00 pm L01, KN Opening Remarks and Opening Plenary Keynote:
De Novo Peptide Design
Dr. David Baker, University of Washington
Session Chairs:
John Vederas, University of Alberta
Jonathan Lai, Albert Einstein College of Medicine
Introduces David Baker
Sea to Sky Ballroom A
07:00 pm - 10:00 pm Opening Reception Grand Foyer

Sunday, June 18, 2017

07:30 am - 04:30 pm Registration Grand Foyer
08:00 am - 08:15 am Opening Remarks:
John Vederas, University of Alberta
Jonathan Lai, Albert Einstein College of Medicine
Sea to Sky Ballroom A
08:15 am - 10:05 am SESSION 1
Peptides and Enzymes
Session Chairs:
Dewey McCafferty, Duke University,
Fa Liu, Novo Nordisk
Sea to Sky Ballroom A
08:15 am - 08:40 am L02 - Peptide Probes of Epigenetic Demethylation Complex Protein-Protein Interactions
Dewey McCafferty
Duke University
08:40 am - 09:00 am L03 - Modulation of the Primary and Secondary Structure of Apelin to Optimize Stability, Bias Signalling and Modulate Pathophysiological Response
Éric Marsault
, Université de Sherbrooke/td>
09:00 am - 09:25 am L04 - Understanding and Engineering Bifunctional Enzymes for Nonribosomal Peptide Synthesis
Sylvie Garneau-Tsodikova
University of Kentucky
09:25 am - 09:45 am L05 - Clarifying the Complexity of Chromatin with Peptide Chemistry
Champak Chatterjee
University of Washington
09:45 am - 10:05 am L06 - Peptide Ligases: Site-specific Molecular Staplers
James Tam
Nanyang Technological University
10:05 am - 10:30 am Coffee with Exhibitors & Posters Grand Foyer
Sea to Sky Ballroom B & C
10:30 am - 12:20 pm SESSION 2
Membrane Active Peptides
Session Chairs:
Natia Tsomaia, IPSEN
Charles Deber, University of Toronto
Sea to Sky Ballroom A
10:30 am - 10:55 am L07 - Membrane Interactions and Cell Penetrating Properties of Cyclotides
David Craik
The University of Queensland
10:55 am - 11:20 am L08 - Solid-State NMR Spectroscopy Reveals the Allosteric Regulation of the Sarcoplasmic Reticulum
Ca2+-ATPase by Phospholamban
Gianluigi Veglia
University of Minnesota
11:20 am - 11:35 am L09, YI - Structure-Guided Development of a Peptide Antagonist for EphA4, A Cell-Surface Receptor Linked to Neurodegeneration
Erika J. Olson
The Scripps Research Institute
11:35 am - 12:00 pm L10 - Peptides as Alternatives to Antibiotics
Bob Hancock
University of British Columbia
12:00 pm - 12:20 pm L11 - A New, Quantitative Assay for Cytosolic Penetration of Peptides and other Molecules
Joshua Kritzer
Tufts University
12:20 pm - 01:45 pm Lunch - provided Grand Foyer
Sea to Sky Ballroom B & C
12:15 pm - 01:45 pm International Liaison Meeting TBD
01:50 pm - 03:30 pm SESSION 3
Peptide Synthesis, Structure, Function
Session Chairs:
David Craik, The University of Queensland
Michael Kay, University of Utah
Sea to Sky Ballroom A
01:50 - 02:15 pm L12 - Protein-peptide Interactions that Control Apoptosis
Amy Keating
Massachusetts Institute of Technology
02:15 pm - 02:40 pm L13 - Application of N-Sulfanylethylanilide (SEAlide) Unit to Protein Chemical Synthesis and Protein Enrichment
Akira Otaka
Tokushima University
02:40 pm - 03:05 pm L14 - Rational Redesign of the Collagen Triple Helix Interface
David Chenowith
University of Pennsylvania
03:05 pm - 03:30 pm L15 - Linear and Cyclic Azapeptide Strategies for Conceiving Cluster of Differentiation-36 Scavenger Receptor Modulators
William Lubell
Université de Montréal
03:30 pm - 03:50 pm L16 - Bulky Dehydroamino Acids Impart Proteolytic Stability to Peptides
Steven Castle
Brigham Young University
04:00 pm - 05:30 pm Merrifield Award Lectures
Sea to Sky Ballroom A
04:00 pm - 04:05 pm Introduction:
Philip Dawson, The Scripps Research Institute
04:05 pm - 04:45 pm L17, AW - The Use of Synthetic Peptides to Probe Complex Interactions in Proteins and the Development of Synthetic Peptide Drugs and Vaccines
Robert Hodges
University of Colorado School of Medicine
04:45 pm - 04:50 pm Introduction:
Philip Dawson, The Scripps Research Institute
04:50 pm - 05:30 pm L18, AW - Peptides in Membranes: From Structure to Drug Design
Charles Deber
University of Toronto
07:00 pm - 09:00 pm Student Mixer Garibaldi

Monday, June 19, 2017

07:30 am - 04:30 pm Registration Grand Foyer
08:00 pm - 10:10 am SESSION 4
Post-Translational and Chemical Modifications
Session Chairs:
Michael Burkart, University of California, San Diego
Justin Holub, Ohio University
Sea to Sky Ballroom A
08:00 am - 08:25 am L19 - Engineering Protein Interactions in Type II Non-Ribosomal Peptide Synthetases
Michael Burkart
University of California, San Diego
08:25 am - 08:50 am L20 - Cross-Talk Between Chromatin Recognition and Modification in Histone Demethylases
Danica Fujimori
, University of California, San Francisco
08:50 am - 09:05 am L21, YI - Affecting Activity of the Linear Ubiquitin Chain Assembly Complex, LUBAC, with Stapled Alpha-Helical Peptides
Amanda Whiting
National Cancer Institute
09:05 am - 09:30 am L22 - Genetically-Encoded Chemically-Modified Peptides
Ratmir Derda
University of Alberta
09:30 am - 09:50 am L23 - Affinity Labeling of Histone Peptides Containing Trimethyllysine
Marcey Waters
University of North Carolina, Chapel Hill
09:50 am - 10:10 am L24 - New Coumarin- and Nitrodibenzofuran-Based Photoremovable Protecting Groups for Cysteine Protection in Solid Phase Peptide Synthesis
Mark DiStefano
University of Minnesota
10:10 am - 10:30 am Coffee with Exhibitors & Posters Grand Foyer
Sea to Sky Ballroom B & C
10:30 am - 12:10 pm SESSION 5
Computational Design and Recognition
Session Chairs:
David Baker, University of Washington,
Jung-Mo Ahn, University of Texas at Dallas
Sea to Sky Ballroom A
10:30 am - 10:55 am L25 - Using Theory and Computation to Design Polypeptide Materials
Jeffery Saven
University of Pennsylvania
10:55 am - 11:20 am L26 - Tertiary Alphabet for the Observable Structural Universe
Gevorg Grigoryan
Dartmouth College
11:20 am - 11:45 am L27 - Accurate Structural Modeling and High-Affinity Design of Peptide-Protein Interactions using Rosetta FlexPepDock
Ora Schueler-Furman
Hebrew University of Jerusalem
11:45 am - 12:00 pm L28, YI - Development of a Peptide Macrocycle FXII Inhibitor for Safe Anticoagulation Therapy
Jonas Wilbs
Ecole Polytechnique Fédérale de Lausanne
12:00 pm - 12:20 pm L29 - Minimalist Protein ME47 Targets the Myc/Max:E-box DNA Network and Decreases Tumor Xenograft Growth
Jumi Shin
University of Toronto
12:20 pm - 01:45 pm Lunch - provided Grand Foyer
Sea to Sky Ballroom B & C
01:50 pm - 03:30 pm SESSION 6
Peptidomimetics and Non-Natural Backbones
Session Chairs:
Sam Gellman, University of Wisconsin at Madison
Kit Lam, University of California at Davis
Sea to Sky Ballroom A
01:50 pm - 02:15 pm L30 - Impact of Backbone Modifications on Informational Properties of Peptides
Sam Gellman
University of Wisconsin-Madison
02:15 pm - 02:40 pm L31 - Interfacing Oligourea Foldamers with Alpha-Peptides: An Approach to Alpha-Helix Mimicry and to the Creation of Composite Protein-Like Architectures
Gilles Guichard
University of Bordeaux and CNRS
02:40 pm - 03:05 pm L32 - Peptide N-Amination: A Versatile Backbone Modification for Constrained Proteomimetics
Juan Del Valle
University of South Florida
03:05 pm - 03:25 pm L33 - Targeting Protein-Protein Interactions with Peptide-based Inhibitors
Kristian Strømgaard
University of Copenhagen
03:40 pm - 04:05 pm L34, AW - Goodman Lecture
From Venoms to Drugs
Paul Alewood
The University of Queensland
Ved Srivastava, Intarcia Therapeutics
04:05 pm - 05:35 pm SESSION 7
Peptide Therapeutics and Diagnostics I
Session Chairs:
Les Miranda, Amgen
Waleed Danho
Sea to Sky Ballroom A
04:05 pm - 04:30 pm L35 - From Twice-daily Injection to Once or Twice a Yearly Dosing of GLP-1 Agonist for Potential Treatment for Type 2 Diabetes
Ved Srivastava
Intarcia Therapeutics
04:30 pm - 04:55 pm L36 - Development of a Potent D-Protein Inhibitor of VEGF-A with Reduced Immunogenicity and a Longer Half-Life
Dana Ault-Riche
Reflexion Pharmaceuticals
04:55 pm - 05:15 pm L37 - Conformational, Topographical, Receptor and Dynamic Consideration in the Design of Biostable, Receptor Selective Ligands for the Melanocortin Receptors
Victor Hruby
University of Arizona
05:15 pm - 05:35 pm L38 - Breast Cancer Targeting Peptides and Peptide-Drug Conjugates for Increased Therapeutic Efficacy of Current Chemotherapeutic Drugs against Triple Negative Breast Cancer
Kamaljit Kaur
Chapman University
05:35 pm - 08:00 pm Group 1 Poster Session
Grand Foyer
Sea to Sky Ballroom B & C

Tuesday, June 20, 2017

07:30 am - 12:30 pm Registration Grand Foyer
08:00 am - 08:35 am L39, AW - du Vigneaud Lecture I
Chemical Forces that Stabilize Proteins
Ronald Raines
University of Wisconsin
Robin Offord, Mintaka Foundation
Sea to Sky Ballroom A
08:35 am - 10:05 am SESSION 8
Session Chairs:
James Paulson, The Scripps Research Institute
Fernando Albericio, University of KwaZulu-Natal
Sea to Sky Ballroom A
08:35 am - 09:00 am L40 - HIV Glycosylation
James Paulson
The Scripps Research University
09:00 am - 09:25 am L41 - Microbial Natural Products Discovery and Diversification
Jon Thorson
University of Kentucky
09:25 am - 09:50 am L42 - Elucidating the Features of Effective Vaccines
Laura Kiessling
University of Wisconsin
09:50 am - 10:05 am L43, YI - Engineering Dengue EDIII Immunogens to Elicit Broadly Neutralizing Antibody Responses
Julia C. Frei
Albert Einstein College of Medicine
10:05 am - 10:30 am Coffee with Exhibitors & Posters Grand Foyer
Sea to Sky Ballroom B & C
10:30 am - 11:00 am L44, AW - Makineni Lecture
Novel Peptide-like Inhibitors of the Proteasome Ubiquitin Receptor Rpn13 Proteasome Inhibitors and Their Mechanism of Action: A Promising New Approach to Chemotherapy
Thomas Kodadek
The Scripps Research University
Marcey Waters, University of North Carolina, Chapel Hill
Sea to Sky Ballroom A
11:00 am - 12:45 am SESSION 9
Synthetic Methods
Session Chairs:
Stephen Kent, University of Chicago,
Andrei Yudin, University of Toronto
Sea to Sky Ballroom A
11:00 am - 11:25 am L45 - Automated Flow Peptide Synthesis: Toward Amide Bonds at Nature’s Pace
Bradley Pentelute
Massachusetts Institute of Technology
11:25 am - 11:50 am L46 - Organotrifluoroborates as Radioprosthetics that Enable Facile, User-friendly 18F-Labeling for Turning Peptides into Pet Imaging Agents
David Perrin
University of British Columbia
11:50 am - 12:10 pm L47 - Peptide Therapeutics Method Development: Increasing Efficiency and Purity of SPPS using Parallel Synthesis Optimization with Induction Heating
James Cain
Gyros Protein Technologies
12:10 pm - 12:30 pm L48 - Cyclic Urethane Chemistry for Synthesis and Sequencing of Cyclic Peptides
Monika Raj
Seton Hall University
12:30 pm - 12:50 pm L49 - A New Level of Efficiency for SPPS
Jonathan Collins
CEM Corporation
12:50 pm - 02:50 pm Dr. Bert L. Schram Young Scientists’ Lunch & Mixer
Graduate students & post-docs only
12:50 pm - 02:00 pm Peptide Science Editorial Board Lunch & Meeting
Editors and Editorial Advisory Board
03:00 pm - 05:00 pm Workshop on Career Development: Job Search Strategy and Preparation.
Organized by Natia Tsomaia, IPSEN
Ellie Eckhoff
Senior Vice President, ClearRock, Inc.
Sponsored by Scilligence

Wednesday, June 21, 2017

07:30 am - 04:00 pm Registration Grand Foyer
08:00 am - 08:35 am L50, AW - du Vigneaud Lecture II
Combinatorial Lanthipeptide Biosynthesis
Wilfred van der Donk
Howard Hughes Medical Institute and University of Illinois at Urbana-Champaign
John Vederas, University of Alberta
Sea to Sky Ballroom A
08:35 am - 10:10 am SESSION 10
Peptide Therapeutics and Diagnostics II
Session Chairs:
Thomas Kodadek, The Scripps Research Institute
Wendy Hartsock, Ferring Research Institute, Inc.
Sea to Sky Ballroom A
08:35 am - 09:00 am L51 - Discovery of Macrocyclic Peptidomimetics Targeting Protein-Protein Interactions
Hyun-Suk Lim
Pohang University of Science and Technology
09:00 am - 09:25 am L52 - Discovery of Soluble, Biophysically Stable Glucagon Analogs with Minimal Change to Native Sequence
John Mayer
Novo Nordisk Research Center
09:25 am - 09:50 am L53 - Systematic Discovery and Development of Peptidic Molecular Guidance Systems for the Diagnosis and Treatment of Cancer
Kathlynn Brown
SRI International
09:50 am - 10:10 am L54 - Sensitivity of the Opioid Activity Profile of CJ-15,208 Analogs to Ring Substitution
Jane Aldrich
University of Florida
10:10 am - 10:35 am Coffee with Exhibitors & Posters Grand Foyer
Sea to Sky Ballroom B & C
10:35 am - 12:05 pm SESSION 11
Peptide Libraries
Session Chairs:
Hiroaki Suga, The University of Tokyo
Richard Houghten, Torrey Pines Institute
Sea to Sky Ballroom A
10:35 am - 11:00 am L55 - The RaPID Discovery of Pseudo-Natural Peptides
Hiroaki Suga
The University of Tokyo
11:00 am - 11:25 am L56 - From Natural Antibodies to Synthetic Proteins
Sachdev Sidhu
University of Toronto
11:25 am - 11:40 am L57, YI - Peptide Macrocyclization Inspired by Non-Ribosomal Imines
Lara Malins
The Scripps Research Institute
11:40 am - 12:05 pm L58 - An Engineered Tumor Targeting Knottin Peptide is a Versatile Agent for Imaging, Drug Delivery, and Immunotherapy
Jennifer Cochran
Stanford University
12:10 pm - 12:20 pm Announcement of 26th APS Sea to Sky Ballroom A
12:20 pm - 01:45 pm Lunch - provided TBA
12:20 pm - 01:45 pm Vincent du Vigneaud Award Lunch
Sponsored by BACHEM
By Invitation
03:40 pm - 05:35 pm SESSION 12
Constrained Peptides and Macrocycles
Session Chairs:
Paramjit Arora, New York University
Federico Bernal, National Cancer Institute
Sea to Sky Ballroom A
03:40 pm - 04:05 pm L59 - Minimal Coiled Coils and their Potential as Protein-Protein Interaction Inhibitors
Paramjit Arora
New York University
04:05 pm - 04:30 pm L60 - Targeting Kinase Regulation with Constrained Peptides
Eileen Kennedy
University of Georgia, College of Pharmacy
04:30 pm - 04:45 pm L61, YI - Oxadiazole Grafts in Peptide Macrocycles
Solomon Appavoo
University of Toronto
04:45 pm - 05:10 pm L62 - How Do Cell-Penetrating Peptides Work?
Dehua Pei
The Ohio State University
05:10 pm - 05:35 pm L63 - Exploring Macrocyclic Peptide Cell Permeability: Stapled p53 Peptide Model System
Tomi Sawyer
Merck & Company, Inc.
05:35 pm - 08:00 pm Group 2 Poster Session
Grand Foyer
Sea to Sky Ballroom B & C

Thursday, June 22, 2017

07:30 am - 10:30 am Registration Grand Foyer
08:15 am - 10:10 am SESSION 13
Natural Product Biosynthesis
Session Chairs:
Wilfred van der Donk, University of Illinois
Yuki Goto, The University of Tokyo
Sea to Sky Ballroom A
08:15 am - 08:40 am L64 - In Vitro Reconstitution and Mechanistic Insights into Thiopeptide Biosynthesis
Douglas Mitchell
University of Illinois at Urbana-Champaign
08:40 am - 09:05 am L65 - Biosynthesis of RiPPs on the Coral Reef
Eric Schmidt
University of Utah
09:05 am - 09:20 am L66, YI - Enzymatic Macrocyclization of Non-Natural and Hybrid Polyketide Peptides”
Emilia Oueis
University of St Andrews
09:20 am - 09:45 am L67 - Making and Breaking Lasso Peptides
A. James Link
Princeton University
09:45 am - 10:10 am L68 - Chemoenzymatic Platforms for the Discovery of New Peptide Therapeutics
Albert Bowers
University of North Carolina, Eshelman School of Pharmacy
10:10 am - 10:35 am Coffee Break Grand Foyer
10:35 am - 12:10 pm SESSION 14
Peptide Materials and Nanomedicine
Session Chairs:
Neal Zondlo, University of Delaware
Bradley Nilsson, University of Rochester
Sea to Sky Ballroom A
10:35 am - 11:00 am L69 - The Design Evolution of Anticancer Peptides from Self-Assembled Hydrogels and How Cancer Cells Gain Resistance to their Action
Joel Schneider
National Cancer Institute
11:00 am - 11:25 am L70 - Intracellular Delivery of Therapeutic Peptide Using Enzymatically Cleavable Peptide Amphiphiles
James LaBelle
University of Chicago
11:25 am - 11:50 am L71 - Protein Misfolding and Chemical Evolution
David Lynn
Emory University
11:50 am - 12:05 pm L72, YI - Palladium in Chemical Protein Synthesis and Manipulation
Muhammad Jbara
Technion-Israel Institute of Technology Haifa
12:05 pm - 12:25 pm L73 - Peptide-CRM197 Conjugate Vaccines - Considerations for Process Development
Anouk Dirksen
Pfizer Inc.
12:25 pm - 01:40 pm Lunch Break - on your own  
01:40 pm 03:15 pm SESSION 15
Peptide Assemblies and Complexes
Session Chairs:
James Nowick, University of California, Irvine
Ivan Korendovych ,Syracuse University
Sea to Sky Ballroom A
01:40 pm - 02:05 pm L74 - Unlocking the Mysteries of Amyloid Diseases with Macrocyclic Beta-Sheet Peptides
James Nowick
University of California, Irvine
02:05 pm - 02:30 pm L75 - Aromatic Foldamer-Based Protein Mimicry and Recognition
Ivan Huc
University of Bordeaux and CNRS
02:30 pm - 02:55 pm L76 - Thioamide Probes for Studying Peptide Stability In Vitro and In Vivo
E. James Petersson
University of Pennsylvania
02:55 pm - 03:15 pm L77 - Protein Evolution Yields Cyclic Peptide Inhibitors of HIV-1 Propagation
Brian McNaughton
Colorado State University
03:15 pm - 04:05 pm Closing Remarks & Thanks
John Vederas & Jonathan Lai
L78 - Inventing Synthetic Peptide & Protein Chemistries to Reveal how Enzymes Work
Stephen Kent
University of Chicago
Philip Dawson, The Scripps Research Institute
06:30 pm - 10:00 pm Closing Banquet Sea to Sky Ballroom A

Our Sponsors

  • IPSENIpsen US, comprised of Ipsen Biopharmaceuticals, Inc., and Ipsen Bioscience, Inc., is driven by a passion to improve the lives of patients. A search for innovative solutions to disabling conditions is at the heart of everything we do. We are inspired to find effective therapeutic options to treat diseases, relieve suffering, and bring value to the community.
  • BACHEMBachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry.
  • BiotageBiotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation and purification.
  • FERRINGFerring Pharmaceuticals Inc. is a research-driven biopharmaceutical company devoted to commercialization of innovative products in the fields of infertility and reproductive health, gastroenterology, gynecology, orthopaedics and urology.
  • Gyros Protein TechnologiesExpertise and deep knowledge in providing peptide synthesis and bioanalytical tools
  • POLYPEP_logoAt PolyPeptide, going the extra mile with our customers is a priority. Agility, global presence, flexibility, ability to create fast-tailored solutions, and exceeding the highest requirements, are all key benefits that you could only expect from a world leader in peptide manufacturing.
  • Reflexion_logo
  • SANOFISanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care.
  • ZEAL&_logoZealand Pharma is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi, Boehringer Ingelheim and Helsinn and a pipeline of proprietary product candidates, which primarily target specialty diseases with significant unmet needs.
  • CPC ScientificCPC Scientific is a global provider of high-quality cGMP and custom peptides to researchers and pharmaceutical companies.
  • DaisogelDAISO offers you highly reproducible and predictable DAISOGEL® analytical and preparative columns for proteins, peptides, and organic compounds.
  • InterchimWe manufacture and distribute consumables and instruments for research and industry.
  • Novo NordiskNovo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
  • CBL PharmaChemical and Biopharmaceutical Laboratories is a global peptide manufacturing technology company founded in 1990 to provide the industry with novel chemistries in key areas of solid phase peptide and organic synthesis.
  • CEMCEM Corporation, a private company based in Matthews, North Carolina, is the leading provider of microwave laboratory instrumentation.
  • ChemPepChemPep®, a bioscience company located in Wellington, Florida, provides innovative products and services for R&D in the areas of organic chemistry, biochemistry, molecular biology, solid phase synthesis, peptide and combinatorial chemistry.
  • Intarcia TherapeuticsIntarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies utilizing the Medici Drug Delivery System™ - medicines that have the potential to transform the prevention and management of serious chronic diseases.
  • MERCKWe are a global healthcare company with a 125-year history of working to make a difference.
  • PEPTIDES INTERNATIONALPeptides International manufactures and distributes a wide variety of products that are used in major research institutions throughout the world.
  • Ra PharmaRa Pharma® utilizes a process called “mRNA display” and the Extreme Diversity™ platform to produce extremely large and diverse libraries of peptides from which to screen for potential product candidates.
  • Peptide ScienceThe aim of Peptide Science is to publish significant original research papers and comprehensive reviews covering the whole spectrum of peptide science including synthesis, structure and bioactivity.
  • ScilligenceScilligence facilitates Science with Intelligence
  • Bioconjugate ScienceBioconjugate Chemistry invites original contributions on all research at the interface between man-made and biological materials.
  • ACS Combinatorial ScienceACS Combinatorial Science publishes research describing the development and use of combinatorial, high-throughput, and related methods in chemistry, materials science, and biology.